Mereo BioPharma Group (MREO) Announced Progress in the Phase 3 Orbit Study Testing UX143
Mereo BioPharma Group plc (NASDAQ:MREO) is one of the Best 52-Week Low Penny Stocks to Buy Now. On July 9, Mereo BioPharma Group, along with Ultragenyx Pharmaceutical Inc., announced progress in the ...